
Joacim Holter
PI
Joacim Holter, CEO of Lifecare (male, 1st time participation to FET), is responsible for business development, finances and stakeholder relations.
He’s experienced includes international business development bringing advanced technologies from R&D to a commercially mature level.
Research Group

Sanja Ramljak
Sanja Ramljak, PhD, Clinical and regulatory management (female, 1st time participation to FET) will be responsible for pre-clinical activities and clinical activities (and event regulatory affairs). She holds a Post Doc at the German Primate Centre and a PhD in Molecular Biology at the University of Göttingen.
Activities
- Lifecare will be responsible for and coordinate the development of the glucose sensors; Integrated, calibration-free, low-power, long-lasting (at least 3 years), intraperitoneal micro-sensor (expected size: 1 x 0.5 x 0.5 mm3) for glucose measurement.
- Leader of WP2 (to develop an innovative ultra-small implantable sensor)
- Design and development of the implantable glucose sensing system with animal proof-of-Concept
- Device optimization and introduction of wireless data transmission with final system accuracy evaluation in human subjects (patients and healthy volunteers)
- Design and development of the sensor data transfer protocol 1
Do you want to receive news and updates on the project?
Fill out the form to receive news about the project
Subscribe to the newsletter